Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The emergence of ketamine as a novel treatment for posttraumatic stress disorder
Adriana Feder, Sarah Rutter, Daniela Schiller, et al.
Advances in pharmacology (2020), pp. 261-286
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 95
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 18
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 93
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 56
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine
Li Ma, Jiancheng Zhang, Yūkō Fujita, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Novel treatments for anorexia nervosa: Insights from neuroplasticity research
Johanna Louise Keeler, Carol Kan, Janet Treasure, et al.
European Eating Disorders Review (2023) Vol. 32, Iss. 6, pp. 1069-1084
Open Access | Times Cited: 21
Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects
Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh, et al.
Ibrain (2023) Vol. 9, Iss. 1, pp. 90-101
Open Access | Times Cited: 19
Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care
Connor T. A. Brenna, Benjamin I. Goldstein, Carlos A. Zarate, et al.
Anesthesiology (2024) Vol. 141, Iss. 2, pp. 222-237
Open Access | Times Cited: 7
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 39
Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
Hewa Artin, Sean Bentley, Eamonn Mehaffey, et al.
EClinicalMedicine (2022) Vol. 48, pp. 101439-101439
Open Access | Times Cited: 23
An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update
Laura Bajor, Charmi Balsara, David N. Osser
Psychiatry Research (2022) Vol. 317, pp. 114840-114840
Closed Access | Times Cited: 23
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence
Agnes Norbury, Sarah Rutter, Abigail B. Collins, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2266-2277
Open Access | Times Cited: 31
Ketamine for post-traumatic stress disorders and it's possible therapeutic mechanism
Muhammad Asim, Bing Wang, Bo Hao, et al.
Neurochemistry International (2021) Vol. 146, pp. 105044-105044
Closed Access | Times Cited: 29
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies
Ani Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
Neuropharmacology (2022) Vol. 218, pp. 109211-109211
Closed Access | Times Cited: 22
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine
Viviana D. Evans, Alejandro Arenas, Kenneth Shinozuka, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e155-e177
Closed Access | Times Cited: 4
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD
Nathan Wellington, Ana Paula Bouças, Jim Lagopoulos, et al.
Psychopharmacology (2025)
Open Access
Hippocampal Dorsal CA1: Functional Connectivity and Role in HCN Channelopathies in Affective Diseases and Epilepsy
Tsz Wei So, Hee Youn Choi, Haoyu Xu, et al.
IBRO Neuroscience Reports (2025)
Open Access
Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study
Jan van Amsterdam, Wim van den Brink
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 1, pp. 83-94
Closed Access | Times Cited: 24
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine
Lynnette A. Averill, Chadi G. Abdallah
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 2, pp. 133-137
Open Access | Times Cited: 16
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
Anya Ragnhildstveit, Laura Jackson, Sarah Cunningham, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Ezio Carboni, Anna R. Carta, E. Carboni, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
Putative Activation of the CB1 Cannabinoid Receptors Prevents Anxiety-Like Behavior, Oxidative Stress, and GABA Decrease in the Brain of Zebrafish Submitted to Acute Restraint Stress
Waldo Lucas Luz, Mateus Santos-Silva, Patrick Bruno Cardoso, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 16
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110609-110609
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top